7 November 2019 - As an oncologist, I was eager to come work at the U.S. FDA, where I knew I could be a part of the positive impact on the lives of so many patients across the U.S. 

FDA is known as a science-based agency with many important public health roles, including facilitating the development of new medical products, and advancing regulatory science to benefit all patients. In that role, it is essential to partner with the people who are impacted the most by disease — patients and their caregivers.

Through my experience treating patients, it became clear that their worries and concerns were not always well matched to the problems the research community was trying to solve. For example, the clinical trial endpoints being studied to support the approval of investigational new drugs were not always relevant to the everyday difficulties my patients experienced.

Read FDA Voices on Policy article